We are live on ! Find out more
DFO

Duquesne Family Office Portfolio holdings

AUM $3.38B
1-Year Est. Return 61.92%
This Fund
S&P 500
This Quarter Est. Return
-16.59%
1 Year Est. Return
+61.92%
3 Year Est. Return
+280.57%
5 Year Est. Return
+393.65%
10 Year Est. Return
+4,147.23%
AUM
$1.38B
AUM Growth
-$923M
Cap. Flow
-$579M
Cap. Flow %
-41.88%
Top 10 Hldgs %
75.1%
Holding
60
New
9
Increased
4
Reduced
14
Closed
17

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$89.2M
2
CRWD icon
CrowdStrike
CRWD
+$41.6M
3
DDOG icon
Datadog
DDOG
+$32.8M
4
MRNA icon
Moderna
MRNA
+$29.7M
5
PANW icon
Palo Alto Networks
PANW
+$27.3M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$199M
2
MSFT icon
Microsoft
MSFT
+$75.9M
3
FCX icon
Freeport-McMoran
FCX
+$64.2M
4
TECK icon
Teck Resources
TECK
+$53.6M
5
PRCT icon
Procept Biorobotics
PRCT
+$39.6M

Sector Composition

Rank Sector Weight
1 Technology 25.2%
2 Consumer Discretionary 18.94%
3 Energy 17.15%
4 Healthcare 10.51%
5 Materials 10.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABCL icon
26
AbCellera Biologics
ABCL
$1.99B
$7.03M 0.51%
659,750
– –
IHS icon
27
IHS Holding
IHS
$2.77B
$6.44M 0.47%
771,096
– –
SMAR
28
DELISTED
Smartsheet Inc.
SMAR
$4.71M 0.34%
149,800
-811,922
-84% -$33.6M
IOT icon
29
Samsara
IOT
$22.3B
$4.48M 0.32%
+400,900
New +$4.84M
OSCR icon
30
Oscar Health
OSCR
$8B
$4.23M 0.31%
994,289
– –
SEDG icon
31
SolarEdge
SEDG
$1.99B
$3.67M 0.27%
13,400
-16,500
-55% -$4.51M
CCC
32
CCC Intelligent Solutions
CCC
$3.83B
$2.59M 0.19%
281,879
– –
RXRX icon
33
Recursion Pharmaceuticals
RXRX
$1.69B
$2.23M 0.16%
273,650
– –
DISH
34
DELISTED
DISH Network Corp.
DISH
$2.02M 0.15%
112,400
– –
RETA
35
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$1.79M 0.13%
58,997
– –
CRBU icon
36
Caribou Biosciences
CRBU
$163M
$1.47M 0.11%
271,430
– –
COMP icon
37
Compass
COMP
$9.4B
$1.44M 0.1%
399,100
– –
PRCT icon
38
Procept Biorobotics
PRCT
$1.14B
$1.28M 0.09%
39,266
-1,088,775
-97% -$39.6M
OPEN icon
39
Opendoor
OPEN
$3.34B
$1.1M 0.08%
240,767
– –
ACAD icon
40
Acadia Pharmaceuticals
ACAD
$4.9B
$1.05M 0.08%
74,400
– –
GLBE icon
41
Global E Online
GLBE
$6.89B
$407K 0.03%
20,180
-555,450
-96% -$12.8M
FTH
42
Faeth Therapeutics
FTH
$631M
$227K 0.02%
5,000
– –
CZOO
43
DELISTED
Cazoo Group Ltd
CZOO
$101K 0.01%
70
– –
ALNY icon
44
Alnylam Pharmaceuticals
ALNY
$28.9B
– –
-63,945
Closed -$10.4M
AMZN icon
45
Amazon
AMZN
$2.94T
– –
-1,219,940
Closed -$199M
BTI icon
46
British American Tobacco
BTI
$127B
– –
-120,950
Closed -$5.1M
EWZ icon
47
iShares MSCI Brazil ETF
EWZ
$9.07B
– –
-144,565
Closed -$5.47M
EXPE icon
48
Expedia Group
EXPE
$36.8B
– –
-56,565
Closed -$11.1M
FLEX icon
49
Flex
FLEX
$45.3B
– –
-319,364
Closed -$4.46M
MOS icon
50
The Mosaic Company
MOS
$7.46B
– –
-143,825
Closed -$9.56M
1
2
3

Similar funds

VFCM
Valley Forge Capital Management Miami, Florida $3.38B AUM 15.93% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
EFM
E Fund Management Guangzhou, China $3.37B AUM
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return
5NCM
59 North Capital Management Houston, Texas $3.35B AUM 22.14% 1-Year Est. Return
MCM
Marsico Capital Management Denver, Colorado $3.4B AUM 51.58% 1-Year Est. Return
QCG
Quadrant Capital Group Cincinnati, Ohio $3.34B AUM 29.16% 1-Year Est. Return

Duquesne Family Office's Q2 2022 Portfolio in Review

As of Q2 2022, Duquesne Family Office held 60 positions worth $1.38B, down 40% from $2.31B the previous quarter. Its ten largest holdings account for 75% of the portfolio.

Duquesne Family Office withdrew a net $579M in Q2 2022, closing 17 positions and reducing 14 holdings. Its most notable exit was Amazon, an estimated $199M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Energy.

Against the trend, Duquesne Family Office opened a new position in Eli Lilly worth $96.3M.

  • Duquesne Family Office's largest Q2 2022 buy was Eli Lilly: 297,150 shares worth $96.3M.
  • Duquesne Family Office added most to Antero Resources in Q2 2022, an estimated $19.3M increase.
  • Duquesne Family Office's biggest Q2 2022 reduction was Microsoft, cutting an estimated $75.9M.
  • Duquesne Family Office fully exited Amazon in Q2 2022, selling an estimated $199M.
  • Duquesne Family Office's ten largest holdings make up 75% of its $1.38B portfolio in Q2 2022.
  • Duquesne Family Office opened 9 new positions and closed 17 in Q2 2022.
  • Duquesne Family Office's portfolio value fell 40% quarter-over-quarter to $1.38B.

Based on Duquesne Family Office's 13F filing for Q2 2022, filed 15 Aug 2022.